Welcome to May Health

We were founded as Ziva Medical, which then integrated into Paris-based accelerator MD Start, and became Ablacare SAS and subsequently renamed to May Health SAS and May Health Inc. We’re a team of seasoned MedTech entrepreneurs with deep experience in product development, validation, and launch.

We want more for people suffering from Polycystic Ovary Syndrome (PCOS) and infertility resulting from PCOS.

The Team

Andrew M. Weiss

Director and Interim Chief Executive Officer

Hugh E. Magen

Chief Technical Officer

Rich Ferrick

Vice President, Quality Assurance/Regulatory Affairs

Christina Hawley

Vice President, Clinical Affairs

Cindy Domecus

Chief Regulatory Advisor

Edward Evantash, MD

Chief Medical Advisor

Matt Franklin

Acting Chief Financial Officer

Olivia Ayanruoh

Clinical Trial Associate

Julie Brucker

Clinical Project Manager

Theo Ha

Sr. QA Manager

Joshua Ino

Sr. R&D Engineer

Angela Mendez

Clinical Data Manager

Scott Morimune

Director of Operations

Bertha Torres

Director, Clinical Affairs

Willis Wung

R&D Engineer

Jane Price

Sr. Clinical Site Manager

Fernando Moreno

Office Manager AP Specialist

Neil Barman, MD

Medical Advisor

Tracy Rodriguez

Associate Director, Site Support Program

Join Our Team

Board of Directors

Antoine Papiernik

Managing Director,
Sofinnova Partners

Anne Osdoit

Partner,
Sofinnova Partners - MD Start

Bob Auerbach, MD

Board Chair,
Cooper Surgical

Andrew M. Weiss

Director and Venture Advisor

Neil Barman, MD

Co-Founder,
Ziva Medical

Investors

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact our collective future.

Founded in 1972, Sofinnova Partners is a deeply established venture capital firm in Europe, with 50 years of experience backing over 500 companies and creating market leaders around the globe. Today, Sofinnova Partners has over €2.5 billion under management. For more information, please visit: sofinnovapartners.com.

MD Start is Sofinnova’s in-house medtech accelerator led by a team of seasoned medtech entrepreneurs and investors with extensive operational experience in high-growth early-stage medical device companies. Currently in its third iteration, MD Start has a successful track record of catalyzing innovative technology from conception to the clinic. More information: https://sofinnovapartners.com/strategy/md-start

Trill Impact is a pioneering Impact House with around EUR 1.2 billion in assets under management across its investment strategies, Impact Private Equity, Impact Ventures and Microfinance, with a team of around 55 experienced professionals based in the Nordics, Germany, Luxembourg and USA. Trill Impact aims to become a force for positive change through impact private investments, delivering Real Returns and Lasting Impact for the benefit of investors, businesses and society at large — encouraging others to follow. For more information, please visit: www.trillimpact.com

Bpifrance Investissement is the management company that handles Bpifrance’s equity investments. Bpifrance is the French national investment bank: it finances businesses — at every stage of their development — through loans, guarantees, equity investments and export insurances. Bpifrance also provides extra financial services (training, consultancy) to help entrepreneurs meet their challenges from innovation to export.For more information, please visit: www.bpifrance.com